Glenmark Pharmaceuticals informs about press release

22 Aug 2023 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed a Press Release issued by its wholly owned subsidiary company Glenmark Pharmaceuticals Inc., USA relating to entering into an agreement with U.S. Department of Justice, Antitrust Division (DOJ).

The above information is a part of company’s filings submitted to BSE. 

Glenmark Pharma Share Price

1459.30 -6.00 (-0.41%)
22-Nov-2024 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.85
Dr. Reddys Lab 1203.00
Cipla 1481.00
Lupin 2051.95
Zydus Lifesciences 942.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.